JPS61204129A - ジヤコウ類似効果成分の製法 - Google Patents
ジヤコウ類似効果成分の製法Info
- Publication number
- JPS61204129A JPS61204129A JP60045365A JP4536585A JPS61204129A JP S61204129 A JPS61204129 A JP S61204129A JP 60045365 A JP60045365 A JP 60045365A JP 4536585 A JP4536585 A JP 4536585A JP S61204129 A JPS61204129 A JP S61204129A
- Authority
- JP
- Japan
- Prior art keywords
- musk
- solvent
- sheep
- extract
- gonad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 230000000694 effects Effects 0.000 title abstract description 24
- 241001494479 Pecora Species 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 14
- 210000002149 gonad Anatomy 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000004615 ingredient Substances 0.000 claims description 9
- 238000009826 distribution Methods 0.000 claims description 4
- 210000001550 testis Anatomy 0.000 abstract description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002798 polar solvent Substances 0.000 abstract description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 abstract description 3
- -1 ROKUSHINGAN Substances 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 239000012454 non-polar solvent Substances 0.000 abstract description 2
- 239000003208 petroleum Substances 0.000 abstract description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- 238000005192 partition Methods 0.000 abstract 2
- 239000009470 kyumeigan Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 235000019833 protease Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001493546 Suina Species 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001416180 Moschidae Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 241000125205 Anethum Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 210000001643 allantois Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108010027678 lagenin Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60045365A JPS61204129A (ja) | 1985-03-06 | 1985-03-06 | ジヤコウ類似効果成分の製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60045365A JPS61204129A (ja) | 1985-03-06 | 1985-03-06 | ジヤコウ類似効果成分の製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61204129A true JPS61204129A (ja) | 1986-09-10 |
| JPH0521091B2 JPH0521091B2 (enrdf_load_stackoverflow) | 1993-03-23 |
Family
ID=12717242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60045365A Granted JPS61204129A (ja) | 1985-03-06 | 1985-03-06 | ジヤコウ類似効果成分の製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61204129A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06145184A (ja) * | 1991-08-22 | 1994-05-24 | Koukandou:Kk | 循環器に影響を及ぼす成分の製法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5829711A (ja) * | 1981-08-17 | 1983-02-22 | Koukandou:Kk | ジャコウ類似生薬 |
-
1985
- 1985-03-06 JP JP60045365A patent/JPS61204129A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5829711A (ja) * | 1981-08-17 | 1983-02-22 | Koukandou:Kk | ジャコウ類似生薬 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06145184A (ja) * | 1991-08-22 | 1994-05-24 | Koukandou:Kk | 循環器に影響を及ぼす成分の製法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0521091B2 (enrdf_load_stackoverflow) | 1993-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Linn et al. | Coenzyme Q. VII. Isolation and distribution of coenzyme Q10 in animal tissues | |
| Lam et al. | Isolation and identification of kahweol palmitate and cafestol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse | |
| JPS6210240B2 (enrdf_load_stackoverflow) | ||
| WO2010032269A2 (en) | Anti-inflammatory activity of the iridoid glycosides | |
| Brownie et al. | The in vitro enzymic hydroxylation of steroid hormones. 2. Enzymic 11β-hydroxylation of progesterone by ox-adrenocortical mitochondria | |
| US3956491A (en) | Medicine containing the main sapogenin of helleborus | |
| RU2240304C2 (ru) | Производные гиперфорина, их использование и препараты, содержащие эти производные | |
| CN116283874B (zh) | 一种头花杜鹃杂萜类化合物、提取方法及应用 | |
| JPS61204129A (ja) | ジヤコウ類似効果成分の製法 | |
| US3361630A (en) | Cardiac glycoside | |
| CN105906500B (zh) | 具有脂肪酶抑制作用的绵马次酸类化合物及其应用 | |
| JP3623247B2 (ja) | 茶葉サポニン類を含む薬剤 | |
| US5753697A (en) | Method and pharmaceutical compositions containing rosmanol derivatives | |
| JPH0368516A (ja) | Ｎａ↑＋，Ｋ↑＋‐ＡＴＰａｓｅ阻害剤 | |
| JPH0717859A (ja) | アラキドン酸代謝異常疾患治療剤 | |
| JPS5943927B2 (ja) | 脂質低下剤 | |
| JPS6011017B2 (ja) | ジテルペンアルコ−ルの製法 | |
| JPH0952899A (ja) | ロイコトリエン拮抗剤 | |
| JPH04208221A (ja) | リポキシゲナーゼ阻害剤 | |
| JP2734136B2 (ja) | オクタデセン酸誘導体及びこれを有効成分とする子宮頚癌細胞の殺細胞剤 | |
| CN107536840A (zh) | 一种含20(R)‑人参皂苷Rh1的Sirt1抑制剂及其制备方法和应用 | |
| US3740426A (en) | Pharmacologically effective substance for lowering blood pressure andprocess for isolating it from cabucala madagascariensis | |
| JPH0717857A (ja) | 循環器疾患治療薬 | |
| JPS62164620A (ja) | アンジオテンシンｉ転換酵素阻害剤 | |
| CA1050427A (en) | Pharmaceutical preparation containing the principal helleborus sapogenin |